Third-line treatment options in metastatic pancreatic cancer patients: a real-world study

BACKGROUND: There are currently no standard therapy regimens for the third-line treatment of metastatic pancreatic cancer (mPC) patients. The aim of the present study was to compare the efficacy and safety of different third-line therapy regimens for mPC in the real-world. METHODS: This study retros...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hong-Rui, Zhu, Peng-Fei, Deng, Ya-Ya, Chen, Zhe-Ling, Yang, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552515/
https://www.ncbi.nlm.nih.gov/pubmed/37810973
http://dx.doi.org/10.3389/fonc.2023.1251258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552515/
https://www.ncbi.nlm.nih.gov/pubmed/37810973
http://dx.doi.org/10.3389/fonc.2023.1251258

Ejemplares similares